China grants country's first COVID-19 vaccine patent to CanSino - state media

China's vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its COVID19 vaccine candidate Ad5nCOV, state media reported, citing documents from the country's intellectual property regulator.

from Top Business News- News18.com https://ift.tt/312BepR

• Tweet
• Share
• Share
• Share
• Share